Prospective pivotal trial in 240 participants with T1D aged 6-70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-
Omnipod DASH is a small, wearable insulin delivery device for people with insulin-requiring diabetes. We call it Pod Therapy because it's different than traditional bulky, tubed pumps in the ways that matter most to you. Get Started Today...
Omnipod 5 makes automated†insulin adjustments every five minutes based on continuous glucose monitor (CGM) readings, to improve time in range while lowering HbA1c1,2. With a choice of Sensor integration, you can experience the freedom of AID without switching from your preferred Sensor. And t...